Chanakya Kodishala Jun 2026

: Postdoctoral research at the Mayo Clinic in Rochester, Minnesota.

: Kodishala co-authored longitudinal studies evaluating how various immunosuppressive treatments influence COVID-19 outcomes in patients with rheumatic conditions.

Parallel to his clinical work, Dr. Kodishala has pursued a dedicated research career, primarily centered on the complex relationships between chronic inflammatory diseases (particularly RA) and neurological outcomes, such as dementia. His research has been conducted at some of the world's leading institutions and has resulted in several significant peer-reviewed publications. Chanakya Kodishala

Long before the Reserve Bank of India (RBI) officially proposed the ULI (Unified Lending Interface), Kodishala was experimenting with a "Lending as a Service" (LaaS) model. He built middleware that allowed e-commerce platforms, travel booking sites, and SaaS tools to offer "Buy Now, Pay Later" (BNPL) at checkout without needing their own NBFC license.

Dr. Kodishala’s published research addresses critical gaps in how chronic systemic inflammation affects patients outside of traditional joint-related symptoms. 1. Rheumatoid Arthritis (RA) and Dementia Risk : Postdoctoral research at the Mayo Clinic in

Digital lending in India suffers from high first-party fraud (users who never intend to pay back). Kodishala led the development of a that reduced fraud rates by nearly 40% in one of his previous ventures. By mapping how multiple loan applications came from the same IP address or shared contact lists, the system flagged suspicious clusters before a single rupee was disbursed.

He operates on three core pillars that mirror ancient wisdom: Kodishala has pursued a dedicated research career, primarily

Dr. Chanakya Kodishala is an internal medicine resident and medical researcher specializing in rheumatology and the long-term impacts of chronic inflammatory diseases on aging populations.